US Broker Ratings

AxoGen, Inc. (AXGN) Stock Analysis: Strong Buy Ratings Signal a 22.88% Upside Potential

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices for peripheral nerve regeneration and repair, has been drawing significant attention from investors. With a..

AnaptysBio, Inc. (ANAB) Stock Analysis: A Biotech with 21% Potential Upside

AnaptysBio, Inc. (ANAB) has recently emerged as a compelling opportunity for investors in the biotech sector, particularly those with an eye for innovative developments in immunology therapeutics. Based in San..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 61.57% Potential Upside in Precision Medicine

Relay Therapeutics, Inc. (RLAY) is capturing investor attention with its position as a clinical-stage precision medicines company in the biotechnology industry. With a market capitalization of $1.59 billion, this Cambridge,..

Simulations Plus, Inc. (SLP) Stock Analysis: A 104% Potential Upside Despite Recent Headwinds

Simulations Plus, Inc. (NASDAQ: SLP) stands at an intriguing crossroads for investors, offering a blend of advanced technological solutions in health information services with significant potential upside. Despite recent challenges,..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 37.94% Upside Potential in Biotech

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a dynamic player in the biotechnology sector, is catching the eye of many investors due to its ambitious pursuit of innovative cancer treatments and a..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Uncertain Waters with a Potential Downside

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates an extensive network of general acute care hospitals across the United States. Despite its substantial presence..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Potential Upside of 132% Amid Rising Investor Interest

Iovance Biotherapeutics, Inc. (IOVA), a key player in the biotechnology sector, has been capturing the attention of investors with its innovative approach to cancer treatment. As a commercial-stage biopharmaceutical company,..

Geron Corporation (GERN) Stock Analysis: Eyeing a 106% Potential Upside in the Biotech Arena

For investors with an appetite for high-stakes opportunities in the biotechnology sector, Geron Corporation (NASDAQ: GERN) stands out as a compelling prospect. With a market capitalization of $1.05 billion, this..

Nuvation Bio Inc. (NUVB) Stock Analysis: A Biotech Gem with 104.98% Upside Potential

Nuvation Bio Inc. (NUVB) has been attracting attention in the biotech sector, not least because of its significant upside potential of 104.98%, according to analyst ratings. As a clinical-stage biopharmaceutical..

InMode Ltd. (INMD) Investor Outlook: Exploring a 19.57% Potential Upside in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a key player in the medical devices industry, has been capturing attention with its innovative aesthetic medical products. Headquartered in Yokne’am, Israel, and boasting a market..

AMN Healthcare Services Inc (AMN): Investor Outlook Highlights 16% Potential Upside

AMN Healthcare Services Inc (AMN) stands as a key player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $735.24 million, AMN provides..

Oculis Holding AG (OCS) Stock Analysis: A Promising 52.55% Upside Potential in the Biotech Sector

Oculis Holding AG (OCS), a Switzerland-based clinical-stage biopharmaceutical company, is capturing investor attention with its promising pipeline of ophthalmic treatments and impressive upside potential. Operating within the healthcare sector, specifically..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 71% Upside Potential

Rocket Pharmaceuticals, Inc. (RCKT), a pioneering entity in the biotechnology sector, is capturing attention with its promising pipeline of gene therapies targeting rare and life-threatening diseases. With a market capitalization..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Unveiling a 65% Potential Upside for Investors

In the ever-evolving landscape of biotechnology, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) emerges as a company to watch, particularly for investors seeking opportunities in the healthcare sector. With a market..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a Promising 65.84% Potential Upside in Biotech

Pharvaris N.V. (PHVS) stands out in the biotechnology sector with its promising developments in therapies for rare diseases, particularly those addressing bradykinin-mediated conditions like hereditary angioedema (HAE). Headquartered in Zug,..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A 37% Potential Upside in the Biotech Sector

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a burgeoning player in the biotechnology sector, has recently captured the attention of individual investors due to its promising portfolio in the treatment of severe..

Neuropace, Inc. (NPCE) Investor Outlook: Strong Buy Ratings and a 29.83% Upside Potential

Neuropace, Inc. (NASDAQ: NPCE) stands out in the healthcare sector, particularly within the competitive medical devices industry, thanks to its innovative solutions for drug-resistant focal epilepsy. With its current market..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Potential 140% Upside in the Innovative Oncology Sector

Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering player in the healthcare sector, is gaining attention from investors with its promising potential for substantial upside. Specializing in medical devices for interventional..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a Robust Revenue Growth and Impressive 115.95% Upside Potential

Nutex Health Inc. (NUTX) is carving a prominent niche in the U.S. healthcare sector, focusing on the development and management of micro-hospitals and related healthcare services. With a market capitalization..

Akso Health Group (AHG) Stock Analysis: Navigating Turbulent Waters with a -68.29% ROE

Akso Health Group (NASDAQ: AHG), a key player in the medical distribution sector in China, is capturing the attention of investors with its current challenges and potential future opportunities. Operating..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds